Consensus Transgene

Stocks

TNG

FR0005175080

Biotechnology & Medical Research

Market Closed - Euronext Paris 16:55:00 14/09/2026 BST			5-day change	1st Jan Change
0.8780 ^EUR	-0.34%		-2.44%	-8.54%

09-08	Transgene Expands ProBioGen Partnership With Additional License	MT
09-03	Transgene jumps 20% on positive cancer vaccine data in early trial	RE

Evolution of the Average Target: Transgene

Evolution of the Target Price: Transgene

Changes in Analyst Recommendations: Transgene

b0b11aaab5e6.y8CYGOGvz862S-qbnz7gBXAe7zWhgxPFWPTnyrb1Y30._JXRdtPshbnhc5rv2n2sdQJ2t2zFzCSabMyBmOKyLzO6h8Jps96cgPUIuw~ee727608ab0248eeca689befce5b943b

Analysts' recommendations: Transgene

06-25	Oddo BHF Stays Positive on Transgene
04-07	Transgene stands out following licensing agreement with NEC Bio
11-27	Oddo BHF Lowers Target Price on Transgene but Remains Upbeat
13/10/25	Transgene and BioInvent International AB Jointly Present a Poster on Transational Data and Updated Clinical Results from the Phase I Study of BT-001	CI
18/09/25	Transgene: analysts reiterate their recommendations after results
17/09/25	The day the Fed resumed its rate cuts
06/11/24	Transgene: Invest Securities remains Buy
15/10/24	Transgene: Invest Securities confirms its Buy recommendation
26/09/24	Transgene: Invest Securities confirms its opinion
06/06/23	Transgene: Invest Securities confirms its Buy rating
05/06/23	Transgene: Invest Securities reiterates its recommendation
22/03/23	Transgene: Invest Securities reduces its target
10/01/23	Transgene: Invest Securities confirms its Buy rating

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TRANSGENE			-	-	+24.86%
	WUXI APPTEC CO., LTD.					+23.69%
	ARGENX SE					+18.14%
	INSMED INCORPORATED					+54.69%
	WUXI BIOLOGICS (CAYMAN) INC.					+23.66%
	BIONTECH SE					+23.2%
	GENMAB A/S					+17.29%
	PHARMAESSENTIA CORPORATION					+9.16%
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.					+32.94%
	SUMMIT THERAPEUTICS INC.					+66.2%
	Average					+29.38%
	Weighted average by Cap.					+26.93%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.8780EUR

Average target price

1.100EUR

Spread / Average Target

+25.28%

High Price Target

1.100EUR

Spread / Highest target

+25.28%

Low Price Target

1.100EUR

Spread / Lowest Target

+25.28%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
TNG Stock
Consensus Transgene

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!